Improving Symptom Management for Survivors of Young Adult Cancer
改善年轻成人癌症幸存者的症状管理
基本信息
- 批准号:10016233
- 负责人:
- 金额:$ 17.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-11 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAddressAftercareAreaAwardBehaviorBehavioralBehavioral SymptomsBreast Cancer survivorCancer InterventionCancer SurvivorCaringClinicalClinical Trials DesignCognitiveConsultationsCoping SkillsDataDevelopmentDiagnosisDietDistressEconomicsEducationEducational process of instructingFatigueFocus GroupsFundingGerm cell tumorGoalsGuidelinesHealthHealthcareHematologic NeoplasmsHome environmentHybridsInstitute of Medicine (U.S.)InstitutesInterventionLate EffectsLeadLifeLinkLong-Term EffectsMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMediatingMediator of activation proteinMelanoma CellMentorsMonitorNational Cancer InstituteNotificationOncologyOutcomeOutcome StudyPainParticipantPatient Outcomes AssessmentsPatientsPatternPersonal SatisfactionPersonsPhysical activityProviderPsychologistRandomizedRandomized Clinical TrialsResearchResearch DesignResearch PersonnelResourcesSchoolsSelf EfficacySeveritiesStatistical MethodsStructureSurvival RateSurvivorsSymptomsTechnologyTeenagersTestingTimeTrainingWaiting ListsWeight maintenance regimenWorkagedarmbasecancer cellcancer therapycancer typecareeremotional distressevidence baseexperiencefollow-upimprovedmHealthmalignant breast neoplasmmembermobile applicationnoveloncology programpeerpeer supportphysical symptompilot trialpreventprogramsprototypepsychological symptomrecruitskillsskills trainingsocialsocial cognitive theorysocial relationshipssurvivorshipsymptom managementsymptomatic improvementtherapy designtreatment armyoung adult
项目摘要
More than 60,000 young adults (YAs) aged 18-39 are diagnosed with cancer in the US each year. Advances in
treatment have yielded five year survival rates >70% suggesting that the majority of YAs will become long-term
cancer survivors. Symptom (e.g., pain, fatigue, distress) interference is common for YA cancer survivors and
impacts their abilities to achieve normative life goals (e.g., returning to work/school, achieving autonomy,
pursuing social/romantic relationships) and adhere to recommended follow-up care. Symptom management has
been identified as a significant issue in the transition to survivorship for YAs by the Institute of Medicine and
National Cancer Institute, and assistance with symptom management is rated as an important and unmet need
by YA survivors. Yet, behavioral symptom management interventions have not targeted the needs of those
diagnosed as YAs. The proposed study aims to develop and test the feasibility and acceptability of a novel
behavioral symptom management intervention designed for survivors of YA cancer (cancer types: hematologic,
breast, or gastrointestinal cancers, melanoma, or germ cell tumors). The hybrid intervention will include in-
person, group sessions and an integrated mobile application. The intervention will provide peer support while
also teaching skills to improve symptoms, symptom interference, and self-efficacy for symptom management.
The mobile application will assist with symptom monitoring, home skills practice, and connecting with group
members. The preliminary version of the intervention will be guided by the research team’s prior work developing
and testing symptom management interventions for cancer survivors, national guidelines for YA oncology,
consultation with an expert advisory board, and input from patient (3 groups, n=10/group) and provider (1 group,
N=10) stakeholders obtained during focus groups. The intervention will be further refined following review by
patient user testers (n=10). Next, feasibility, acceptability, and distributions of change over time as well as
relationships between outcome variables will be examined through a pilot randomized clinical trial of the
developed intervention. Participants (N=60) will be randomized to intervention or wait-list control arms. Primary
study outcomes are symptom (pain, fatigue, distress) severity and symptom interference. Self-efficacy and
support will also be examined as mediators of change in outcome variables. The proposed study has the potential
to make several significant contributions by targeting an underserved group of cancer survivors, addressing a
critical gap in care, and addressing variables consistently linked to social, economic, and health burden for YAs.
It will also provide important information about approaches to identify, recruit, and retain YA cancer survivors in
research and provide pilot data for a larger trial. Formal training in the following areas will strengthen the PI’s
ability to become an independent investigator developing, evaluating, and disseminating interventions for YA
cancer survivors: 1) clinical trial design and statistical methods, 2) use of mHealth technology for research and
intervention delivery, 3) needs of cancer survivors diagnosed as YAs, and 4) professional development.
在美国,每年有超过 60,000 名 18-39 岁的年轻人 (YA) 被诊断患有癌症。进展
治疗的五年生存率>70%,这表明大多数 YA 将成为长期患者
癌症幸存者。症状(例如疼痛、疲劳、痛苦)干扰对于 YA 癌症幸存者来说很常见
影响他们实现正常生活目标的能力(例如重返工作/学校、实现自主、
追求社交/浪漫关系)并遵守建议的后续护理。症状管理有
被医学研究所认为是青少年向生存过渡的一个重要问题
美国国家癌症研究所,症状管理援助被评为重要且未满足的需求
由YA幸存者撰写。然而,行为症状管理干预措施并未针对这些人的需求
诊断为 YA。拟议的研究旨在开发和测试新颖的可行性和可接受性
为 YA 癌症幸存者设计的行为症状管理干预措施(癌症类型:血液学、
乳腺癌或胃肠道癌症、黑色素瘤或生殖细胞肿瘤)。混合干预措施将包括:
个人、小组会议和集成的移动应用程序。干预措施将提供同伴支持,同时
还教授改善症状、症状干扰和症状管理自我效能的技能。
该移动应用程序将协助症状监测、家庭技能练习以及与团体联系
成员。干预措施的初步版本将以研究团队之前开发的工作为指导
并测试癌症幸存者的症状管理干预措施、国家青少年肿瘤学指南、
咨询专家咨询委员会,并听取患者(3 组,n=10/组)和提供者(1 组,
N=10) 在焦点小组中获得的利益相关者。经审查后,干预措施将进一步完善
患者用户测试员 (n=10)。接下来,随着时间的推移,可行性、可接受性和变化的分布以及
结果变量之间的关系将通过一项试点随机临床试验进行检查
制定了干预措施。参与者 (N=60) 将被随机分配到干预组或等待名单对照组。基本的
研究结果是症状(疼痛、疲劳、痛苦)的严重程度和症状干扰。自我效能感和
支持也将被视为结果变量变化的中介因素。拟议的研究有潜力
通过针对服务不足的癌症幸存者群体做出多项重大贡献,解决
护理方面的重大差距,并解决与青少年学生的社会、经济和健康负担始终相关的变量。
它还将提供有关识别、招募和留住 YA 癌症幸存者的方法的重要信息。
研究并为更大规模的试验提供试点数据。以下领域的正式培训将增强 PI 的能力
有能力成为一名独立研究者,开发、评估和传播青少年青少年干预措施
癌症幸存者:1) 临床试验设计和统计方法,2) 使用移动医疗技术进行研究和
干预措施的实施,3) 诊断为 YA 的癌症幸存者的需求,以及 4) 专业发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caroline Dorfman其他文献
Caroline Dorfman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caroline Dorfman', 18)}}的其他基金
Improving Symptom Management for Adolescents and Young Adults with Advanced Cancer: Development and Pilot Testing of a Novel Intervention
改善晚期癌症青少年和年轻人的症状管理:新型干预措施的开发和试点测试
- 批准号:
10527066 - 财政年份:2022
- 资助金额:
$ 17.2万 - 项目类别:
Improving Symptom Management for Survivors of Young Adult Cancer
改善年轻成人癌症幸存者的症状管理
- 批准号:
10474989 - 财政年份:2019
- 资助金额:
$ 17.2万 - 项目类别:
Improving Symptom Management for Survivors of Young Adult Cancer
改善年轻成人癌症幸存者的症状管理
- 批准号:
10219205 - 财政年份:2019
- 资助金额:
$ 17.2万 - 项目类别:
Improving Symptom Management for Survivors of Young Adult Cancer
改善年轻成人癌症幸存者的症状管理
- 批准号:
10684000 - 财政年份:2019
- 资助金额:
$ 17.2万 - 项目类别:
Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partners
乳腺癌幸存者和伴侣的行为体重和症状管理
- 批准号:
9404518 - 财政年份:2015
- 资助金额:
$ 17.2万 - 项目类别:
Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partners
乳腺癌幸存者和伴侣的行为体重和症状管理
- 批准号:
8983272 - 财政年份:2015
- 资助金额:
$ 17.2万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 17.2万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 17.2万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 17.2万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 17.2万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 17.2万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 17.2万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 17.2万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 17.2万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 17.2万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 17.2万 - 项目类别:
Research Grant














{{item.name}}会员




